We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Barr, Mylan Receive Favorable Ruling in Mirapex Challenge
Barr, Mylan Receive Favorable Ruling in Mirapex Challenge
June 27, 2008
Barr Laboratories and Mylan Pharmaceuticals have prevailed in a patent infringement case involving generic versions of Boehringer Ingelheim’s Parkinson’s disease drug Mirapex.